{"id":"W4323653185","doi":"10.1007/s13555-023-00913-3","title":"Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial","year":2023,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"AbbVie","keywords":"Medicine; Placebo; Adverse effect; Internal medicine; Randomized controlled trial; Discontinuation; Clinical endpoint","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002554405,0.001627599,0.002968223,0.0003726785,0.0004269893,0.001113391,0.000886271,0.001919057,0.007050871],"category_scores_gemma":[0.001877583,0.0007623092,0.002004155,0.0003438396,0.0009426438,0.0008514455,0.0003214837,0.001999291,0.0009660987],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000586466,"about_ca_system_score_gemma":0.001337156,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004563625,"about_ca_topic_score_gemma":0.0009578956,"domain_scores_codex":[0.999207,0.00042312,0.00006417246,0.0001446044,0.00007502564,0.0000860746],"domain_scores_gemma":[0.9990088,0.0003212815,0.0002696899,0.00007156485,0.00009062585,0.0002379431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9804247,0.004887011,0.0003964193,0.0009333051,0.0007787462,0.00003920275,0.0000389075,0.0001757299,0.002496824,0.00007942461,0.0006146045,0.009135133],"study_design_scores_gemma":[0.9724789,0.02600017,0.000570387,0.00002675743,0.0002465006,0.00001816058,0.000006575274,0.0001559569,0.0001662529,0.00003743673,0.0002871979,0.000005757788],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691923,0.01211687,0.001147552,0.001124002,0.0009287227,0.01028144,0.001896805,0.0002032538,0.003109082],"genre_scores_gemma":[0.9727686,0.00616427,0.002528031,0.001733144,0.000966479,0.01100236,0.001539545,0.00003156051,0.003266124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007050871,"threshold_uncertainty_score":0.02358752,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02630794866463905,"score_gpt":0.3333459065778167,"score_spread":0.3070379579131776,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}